ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Travere Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Travere Therapeutics, INC. (Travere Therapeutics, INC. 401(k) Plan · EIN 27-4842691 · PN 001): $73.52M net assets, 365 active participants, and $2.65 per $10,000 (2.65 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorTravere Therapeutics, INC.
Filing IdentifierTravere Therapeutics, INC. 401(k) Plan · EIN 27-4842691 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$73.52M
Active Participants365
Direct Admin Fee Rate$2.65 per $10,000 (2.65 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI